BRIEF-Biogen Canada's Skyclarys Approved By Health Canada To Treat Friedreich's Ataxia In Patients 16 Years Of Age And Older

Reuters
17 Mar
BRIEF-Biogen Canada's Skyclarys Approved By Health Canada To Treat Friedreich's Ataxia In Patients 16 Years Of Age And Older

March 17 (Reuters) - Biogen Inc BIIB.O:

  • BIOGEN CANADA: HEALTH CANADA APPROVES SKYCLARYS TO TREAT FRIEDREICH'S ATAXIA IN PATIENTS 16 YEARS OF AGE AND OLDER

Source text: ID:nCNWgmy9Wa

Further company coverage: BIIB.O

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10